Petros Pharmaceuticals, Inc. - PTPI Operatsion rentabellik

Ommaviy kompaniya Petros Pharmaceuticals Inc (PTPI) logotipi

Moslashtirilgan operatsion marja Petros Pharmaceuticals (PTPI) kompaniyasining samaradorligini namoyish etadi, bunda 0.00 eng so'nggi darajani ifodalaydi. Barqarorlik logistikaning AQSh hududida to'liq lokalizatsiyasi orqali ta'minlanadi. O'sish Stendra savdolari kengayishi va B2B raqamlashtirishni joriy etishga asoslangan. Telemeditsina xizmatlari va erkaklar salomatligi mahsulotlari orqali diversifikatsiya qilish biznes risklarini minimallashtirib, qo'shimcha chidamlilikni ta'minlaydi.

Petros Pharmaceuticals Inc (PTPI): Operatsion faoliyat rentabelligi 04.07.2022dan 28.06.2025gacha

Petros Pharmaceuticals (PTPI) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
- emitentning bozor qiymati haqida ma'lumotlar:
Kompaniyaning fundamental baholanishi:Petros Pharmaceuticals Inc, PTPI
Petros Pharma asosiy tovari

Operatsion marja soliqlar va foizlar to'lanishidan oldin xarajatlarni boshqarish samaradorligini ko'rsatgan holda, umumiy daromadga nisbatan asosiy operatsiyalardan olingan foyda ulushini o'lchaydi. Petros Pharmaceuticals (PTPI) uchun operatsion marja tendentsiyasini tahlil qilish orqali investor ingredientlar narxining oshishi va tartibga soluvchi o'zgarishlar xatarlariga biznesning chidamliligini baholaydi, bu esa kompaniyaga o'zining retseptsiz sotiladigan dori-darmonlar portfelini kengaytirayotganda xavfsizlik zaxirasini aniqlashga yordam beradi.

Asosiy raqobatchilar

Operatsion rentabellik haleon.com|Operatsion rentabellik KVUE|Operatsion rentabellik Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operatsion foyda bo'yicha marjinallik|Operatsion marja LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operatsion rentabellik|PRGO - Operatsion rentabellik|Alvotech Corp (ALVO) - Sotuvning operatsion marjasi|LQDA: Operatsion marja|Sotuvning operatsion rentabelligi glpg.com (GLPG)|Operatsion rentabellik ANI Pharmaceuticals Inc|MNKD: Operatsion foyda normasi|Sotuvning operatsion marjasi AMPH (Amphastar)|PCRX - Sotuvning operatsion rentabelligi|Operatsion marja SPRY (ars-pharma.com)|Operatsion foyda normasi TBPH|Aquestive Therapeutics, Inc. - Operatsion marja|scpharmaceuticals.com - Operatsion foyda koeffitsiyenti|Tectonic (TECX) - Operatsion rentabellik|Sotuvning operatsion marjasi Tonix Pharmaceuticals Inc.|Operatsion rentabellik sxtchina.com|Sotuvning operatsion marjasi Eupraxia Pharmaceuticals (EPRX)|Operatsion marja BHST|EXOZ - Sotuvning operatsion rentabelligi|Oramed - Sotuvning operatsion marjasi|Entera Bio Ltd. (ENTX) - Sotuvning operatsion rentabelligi|HYFT - Operatsion rentabellik|ABVC: Operatsion rentabellik|CPIX: Operatsion marja|Quantum BioPharma Ltd. - Operatsion foyda normasi|FGEN (FibroGen Corp) - Operatsion marja|Telomir Pharma (TELO) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Operatsion foyda normasi|Operatsion rentabellik Rallybio Corporation RLYB|LEXX: Operatsion foyda bo'yicha sotuv rentabelligi|PULM - Operatsion rentabellik|Operatsion foyda normasi PTHL (Pheton Holdings)|Aptorum (APM) - Operatsion rentabellik|LYRA (Lyra Therapeutics) - Operatsion rentabellik|Operatsion rentabellik Impact BioMedical Inc|TNF Pharmaceuticals - Operatsion foyda marjasi|Operatsion marja YCBD|Operatsion marja PainReform Ltd. (PRFX)|Operatsion rentabellik Altamira Therapeutics Ltd CYTO|LIPO (lipella.com) - Operatsion foyda marjasi|OptiNose - Operatsion marja|Operatsion foyda marjasi PIRS|PROC: Operatsion marja|Qilian International (QLI) - Operatsion marja|Operatsion rentabellik Acelyrin, Inc.|Operatsion marja TFF Pharmaceuticals, Inc.